Financial information

Annexin Pharmaceuticals is a public company, listed on Nasdaq First North Growth Market, Sweden, since April 19th 2017.

• Short name on First North: ANNX
• ISIN-code: SE0009664196
• The shares are administrated by Euroclear Sweden AB